NAFLD Raises Risk for Colorectal Adenomatous Polyps
TOPLINE: Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for precancerous colorectal adenomatous polyps in men and women, ...
TOPLINE: Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for precancerous colorectal adenomatous polyps in men and women, ...
TOPLINE: The indirect and direct costs of alcohol-associated liver disease (ALD) could sap the US economy of $880 billion from ...
Some clinicians say it's "confusing" and "ridiculous" to change the name and diagnostic criteria of an established liver disease, while ...
A contemporary trends analysis shows persistent racial and ethnic disparities in receipt of complex lifesaving procedures for decompensated cirrhosis, including ...
TOPLINE: Nearly half of patients with chronic hepatitis D virus (HDV) infection treated with bulevirtide achieved the combined primary endpoint ...
TOPLINE: Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use lowers the risk for death, cardiovascular disease, decompensated cirrhosis, and liver failure ...
People with nonalcoholic fatty liver disease (NAFLD) are more likely to develop severe infections requiring hospitalization, according to findings from ...
Statins have disease-modifying potential in people with non-cirrhotic chronic liver disease (CLD) by reducing the risk for progression to severe ...
Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) should be considered for patients with acute cholecystitis who are unable to undergo surgery, according to ...
Adding time-restricted eating to a calorie-restricted diet did not provide added benefits in adults with obesity and nonalcoholic fatty liver ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Pharma News Hubb All rights reserved.